Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Even with annotations already declaring readOnly, openWorld, idempotent, and non-destructive behavior, the description adds substantial behavioral detail: cross-source identity spine, source labelling, explicit `unresolved` identifiers, `figi_candidates` on ambiguous matches, graceful degradation when GLEIF or OpenFIGI is unavailable, and internal cascading lookups. There is no contradiction with the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and long, but nearly every clause carries useful information and it is front-loaded with example queries and the 'Use FIRST' directive. The heavy use of nested parentheticals makes it harder to scan, but the content is not wasted.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description adequately covers what the agent will receive: EDGAR identifiers, LEI plus ownership, FIGI with candidates on ambiguity, RxCUI with citation, and explicit unresolved fields. It also covers edge cases like non-US issuers, non-ticker instruments, and service outages, so the agent can set expectations and handle responses correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although the schema covers both parameters, the description adds critical usage nuance beyond the schema: exact input examples like 'AAPL', '0000320193', and 'ozempic', the requirement to pass the entity name only, and the warning that trailing security-class words like 'revenue bonds' will fail FIGI lookup. This materially improves correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries and states the core job: resolving a user-spoken NAME to canonical/official identifiers other tools require as input. It explicitly differentiates itself by saying 'Use FIRST whenever you have a name but need an ID' and by listing the two supported entity types, making its role distinct from sibling tools like entity_profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives strong when-to-use guidance: 'Use FIRST whenever you have a name but need an ID.' It also explains the cascade and how it replaces multiple manual lookups. However, it does not explicitly name sibling alternatives or state when one of those should be chosen instead, so it falls short of full when-not/alternative coverage.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

Several tools have overlapping purposes, e.g., multiple 'ask' tools (ask_pipeworx, ask_pipeworx_grounded, deep_research) and multiple 'compare' tools (compare_entities, scan_competitor_ai_presence). Descriptions are verbose but often don't clearly distinguish when to use each, causing confusion.

Naming Consistency1/5

Naming is highly inconsistent: snake_case (ai_visibility_check), camelCase (polymarket_fill_risk), and arbitrary prefixes (scan_, generate_, etc.). No consistent verb_noun pattern; e.g., 'query_layer' vs 'search_datasets' vs 'layer_info' all involve data retrieval but use different patterns.

Tool Count2/5

33 tools is excessive for a server purportedly focused on ArcGIS Carlsbad. Many tools are unrelated (e.g., polymarket betting, npm package scanning). The core ArcGIS functionality could be covered by 3-5 tools, but the server is bloated with Pipeworx utilities.

Completeness3/5

The ArcGIS portion lacks update/delete capabilities and is limited to querying. The Pipeworx tools cover a broad range of data sources but introduce many dependencies and meta-tools, creating a cluttered surface with dead ends (e.g., tools requiring paid accounts without fallback).